Literature DB >> 31298813

Spasticity and Pain after Spinal Cord Injury: Impact on Daily Life and the Influence of Psychological Factors.

Jacqueline A Tibbett1,2, Edelle C Field-Fote3,4, Christine K Thomas1,2,5, Eva G Widerström-Noga1,5.   

Abstract

BACKGROUND: Spasticity and pain frequently co-occur in persons with spinal cord injury (SCI), yet, how these sequelae interact in daily life is unclear. Additionally, little is known about how psychological factors relate to the perception of spasticity and its impacts on daily life.
OBJECTIVES: (1) Characterize relationships between spasticity and chronic pain with regard to perceived severity, difficulty dealing, and life interference. (2) Determine the extent to which perceived spasticity severity and physiological, psychological, and pain-related factors contribute to impacts of spasticity on daily life (difficulty in dealing, life interference). (3) Determine the effects of painful spasticity on aspects of chronic pain and spasticity (severity, life interference, interference with sleep, and spasm duration).
DESIGN: Observational study.
SETTING: University laboratory. PARTICIPANTS: Twenty participants with SCI and lower extremity spasticity.
METHODS: Measures included International SCI Pain Basic Data Set, Pain and Spasticity Inventories, Difficulty Dealing with Pain/Spasticity, SCI-Spasticity Evaluation Tool, Connor-Davidson Resilience and Moorong Self-Efficacy Scales, Spinal Cord Assessment Tool for Spastic Reflexes, spasm duration, and injury-related and demographic factors. Bivariate correlations, multiple regression analyses, and pairwise comparisons were performed.
RESULTS: Spasticity and chronic pain were directly related, with respect to perceived severity, difficulty dealing, and life interference (rho = 0.514-0.673, P < .05). Shorter injury duration, greater perceived spasticity severity, and greater difficulty dealing with pain explained 61% of variance in difficulty dealing with spasticity. Greater perceived spasticity severity and lower resilience explained 72% of variance in life interference of spasticity. Spasm duration was not significantly associated with perceived spasticity severity. Participants with painful spasticity had significantly greater chronic pain severity (P = .02) and sleep-related impact of spasticity (P = .03) than participants without painful spasticity.
CONCLUSIONS: Perceived severity of spasticity, injury duration, ability to deal with chronic pain, resilience, and painful spasms appear to play important roles in the negative impacts of spasticity on life after SCI. LEVEL OF EVIDENCE: III.
© 2019 American Academy of Physical Medicine and Rehabilitation.

Entities:  

Mesh:

Year:  2019        PMID: 31298813     DOI: 10.1002/pmrj.12218

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  4 in total

1.  The Overexpression of Insulin-Like Growth Factor-1 and Neurotrophin-3 Promote Functional Recovery and Alleviate Spasticity After Spinal Cord Injury.

Authors:  Zuliyaer Talifu; Chuan Qin; Zhang Xin; Yixin Chen; Jiayi Liu; Subarna Dangol; Xiaodong Ma; Han Gong; Zhisheng Pei; Yan Yu; Jianjun Li; Liangjie Du
Journal:  Front Neurosci       Date:  2022-04-29       Impact factor: 5.152

2.  Determining the management of pain in people with spinal cord injury by physiotherapists in South Africa.

Authors:  Bernice James; Mokgadi K Mashola; Diphale J Mothabeng
Journal:  S Afr J Physiother       Date:  2022-07-27

Review 3.  High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?

Authors:  Domenico Intiso; Valentina Simone; Michelangelo Bartolo; Andrea Santamato; Maurizio Ranieri; Maria Teresa Gatta; Filomena Di Rienzo
Journal:  Toxins (Basel)       Date:  2020-05-10       Impact factor: 4.546

4.  Combined Transcutaneous Spinal Stimulation and Locomotor Training to Improve Walking Function and Reduce Spasticity in Subacute Spinal Cord Injury: A Randomized Study of Clinical Feasibility and Efficacy.

Authors:  Stephen Estes; Anastasia Zarkou; Jasmine M Hope; Cazmon Suri; Edelle C Field-Fote
Journal:  J Clin Med       Date:  2021-03-11       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.